Consistent with our experimental findings that CASD1 knockout confers resistance to mitoxantrone and promotes cell survival, we also found that CASD1 expression favors survival in clinical lung Adenocarcinoma (LUAD) samples. This evidence concerns the gene CASD1 and lung adenocarcinoma.